Bentham Science Logo

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 15, 4 Issues, 2020
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Most Accessed Articles



Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211


Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy

, 2006; 1(1): 39-53.

Victoria Cepeda, Miguel A. Fuertes, Josefina Castilla, Carlos Alonso, Celia Quevedo, Manual Soto and Jose M. Perez


DOI: 10.2174/157489206775246430






Recent Development of Anticancer Therapeutics Targeting Akt

, 2011; 6(1): 146-159.

John K. Morrow, Lei Du-Cuny, Lu Chen, Emmanuelle J. Meuillet, Eugene A. Mash, Garth Powis and Shuxing Zhang


DOI: 10.2174/157489211793980079


PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256



Editor-in-Chief

Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.52

Advertisement

October Health DaysPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog